Royalty Pharma (RPRX)
NASDAQ: RPRX
· Real-Time Price · USD
36.07
-0.42 (-1.15%)
At close: Oct 03, 2025, 3:59 PM
36.00
-0.19%
After-hours: Oct 03, 2025, 06:22 PM EDT
-1.15% (1D)
| Bid | 35.5 |
| Market Cap | 15.59B |
| Revenue (ttm) | 2.31B |
| Net Income (ttm) | 1.02B |
| EPS (ttm) | 2.29 |
| PE Ratio (ttm) | 15.75 |
| Forward PE | 7.27 |
| Analyst | Buy |
| Dividends | $1.08 |
| Ask | 36.72 |
| Volume | 2,110,941 |
| Avg. Volume (20D) | 4,023,500 |
| Open | 36.58 |
| Previous Close | 36.49 |
| Day's Range | 36.01 - 36.67 |
| 52-Week Range | 24.05 - 38.00 |
| Beta | 0.59 |
| Ex-Dividend Date | Aug 15, 2025 |
About RPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsRoyalty Pharma is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
+12.56%
Royalty Pharma shares are trading higher after the...
Unlock content with
Pro Subscription
2 months ago · fool.com
Royalty Pharma (RPRX) Q2 Receipts Up 20%Royalty Pharma (RPRX) Q2 Receipts Up 20%
